|
Volumn 112, Issue 1, 2008, Pages 208-209
|
About multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD34 ANTIGEN;
NATALIZUMAB;
MONOCLONAL ANTIBODY;
ALLERGIC ENCEPHALOMYELITIS;
BONE MARROW TRANSPLANTATION;
HEMATOPOIETIC STEM CELL;
HUMAN;
JC VIRUS;
LETTER;
MICROGLIA;
MULTIPLE SCLEROSIS;
MYELOID PROGENITOR CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
VIRUS INFECTION;
ANIMAL;
BLOOD;
DRUG EFFECT;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
IMMUNOLOGY;
MOUSE;
NOTE;
STEM CELL MOBILIZATION;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD34;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
MICE;
MULTIPLE SCLEROSIS;
|
EID: 47249136578
PISSN: 00064971
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2008-04-150813 Document Type: Letter |
Times cited : (2)
|
References (8)
|